Tomoaki Inoue

1.1k total citations
24 papers, 646 citations indexed

About

Tomoaki Inoue is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Tomoaki Inoue has authored 24 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Physiology. Recurrent topics in Tomoaki Inoue's work include Adipose Tissue and Metabolism (4 papers), Heme Oxygenase-1 and Carbon Monoxide (4 papers) and Cardiovascular Function and Risk Factors (3 papers). Tomoaki Inoue is often cited by papers focused on Adipose Tissue and Metabolism (4 papers), Heme Oxygenase-1 and Carbon Monoxide (4 papers) and Cardiovascular Function and Risk Factors (3 papers). Tomoaki Inoue collaborates with scholars based in Japan, Switzerland and United States. Tomoaki Inoue's co-authors include Toyoshi Inoguchi, Noriyuki Sonoda, Ryoichi Takayanagi, Yoshinori Fujimura, Daisuke Miura, Shuji Sasaki, Yasutaka Maeda, Hisashi Yokomizo, Ryoko Takei and Battsetseg Batchuluun and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Tomoaki Inoue

21 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomoaki Inoue Japan 11 266 161 148 113 95 24 646
Hisashi Yokomizo Japan 12 266 1.0× 284 1.8× 146 1.0× 118 1.0× 183 1.9× 26 750
Hiroki Tsuchida Japan 17 336 1.3× 145 0.9× 158 1.1× 66 0.6× 133 1.4× 47 923
Vanessa de Almeida Belo Brazil 18 133 0.5× 101 0.6× 153 1.0× 74 0.7× 91 1.0× 42 829
Lei Pei China 18 505 1.9× 129 0.8× 116 0.8× 61 0.5× 87 0.9× 55 1.1k
Jianning Zhang China 18 647 2.4× 102 0.6× 78 0.5× 62 0.5× 84 0.9× 34 985
Delyth Graham United Kingdom 18 232 0.9× 224 1.4× 153 1.0× 89 0.8× 75 0.8× 32 839
Laura A. Villalobos Spain 8 190 0.7× 153 1.0× 101 0.7× 28 0.2× 76 0.8× 8 613
Kensei Taguchi Japan 15 253 1.0× 86 0.5× 93 0.6× 48 0.4× 55 0.6× 38 680
Martín Alcalá Spain 15 183 0.7× 98 0.6× 285 1.9× 72 0.6× 55 0.6× 29 767
Bardia Askari United States 15 802 3.0× 105 0.7× 175 1.2× 89 0.8× 208 2.2× 20 1.3k

Countries citing papers authored by Tomoaki Inoue

Since Specialization
Citations

This map shows the geographic impact of Tomoaki Inoue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoaki Inoue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoaki Inoue more than expected).

Fields of papers citing papers by Tomoaki Inoue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoaki Inoue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoaki Inoue. The network helps show where Tomoaki Inoue may publish in the future.

Co-authorship network of co-authors of Tomoaki Inoue

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoaki Inoue. A scholar is included among the top collaborators of Tomoaki Inoue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoaki Inoue. Tomoaki Inoue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Inoue, Tomoaki, et al.. (2021). Relationship between serum bilirubin levels, urinary biopyrrin levels, and retinopathy in patients with diabetes. PLoS ONE. 16(2). e0243407–e0243407. 7 indexed citations
3.
Ide, Makoto, Noriyuki Sonoda, Tomoaki Inoue, et al.. (2020). The dipeptidyl peptidase-4 inhibitor, linagliptin, improves cognitive impairment in streptozotocin-induced diabetic mice by inhibiting oxidative stress and microglial activation. PLoS ONE. 15(2). e0228750–e0228750. 32 indexed citations
4.
Takei, Ryoko, Tomoaki Inoue, Noriyuki Sonoda, et al.. (2019). Bilirubin reduces visceral obesity and insulin resistance by suppression of inflammatory cytokines. PLoS ONE. 14(10). e0223302–e0223302. 56 indexed citations
5.
6.
Inoue, Tomoaki, Toyoshi Inoguchi, Noriyuki Sonoda, et al.. (2015). GLP-1 analog liraglutide protects against cardiac steatosis, oxidative stress and apoptosis in streptozotocin-induced diabetic rats. Atherosclerosis. 240(1). 250–259. 87 indexed citations
7.
Yokomizo, Hisashi, Toyoshi Inoguchi, Noriyuki Sonoda, et al.. (2014). Maternal high-fat diet induces insulin resistance and deterioration of pancreatic β-cell function in adult offspring with sex differences in mice. American Journal of Physiology-Endocrinology and Metabolism. 306(10). E1163–E1175. 104 indexed citations
8.
Inoue, Tomoaki, Kunihisa Kobayashi, Toyoshi Inoguchi, et al.. (2013). Downregulation of adipose triglyceride lipase in the heart aggravates diabetic cardiomyopathy in db/db mice. Biochemical and Biophysical Research Communications. 438(1). 224–229. 21 indexed citations
9.
Batchuluun, Battsetseg, Toyoshi Inoguchi, Noriyuki Sonoda, et al.. (2013). Metformin and liraglutide ameliorate high glucose-induced oxidative stress via inhibition of PKC-NAD(P)H oxidase pathway in human aortic endothelial cells. Atherosclerosis. 232(1). 156–164. 139 indexed citations
10.
Maeda, Yasutaka, Toyoshi Inoguchi, Ryoko Takei, et al.. (2012). Chymase inhibition prevents myocardial fibrosis through the attenuation of NOX4‐associated oxidative stress in diabetic hamsters. Journal of Diabetes Investigation. 3(4). 354–361. 22 indexed citations
12.
Inoue, Tomoaki, Isao Ichino, Seiichi Tanaka, et al.. (2010). A case of miliary tuberculosis with type 2 diabetes mellitus complicated with hemophagocytic syndrome, disseminated intravascular coagulation, acute respiratory distress syndrome and acute renal failure. 53(9). 699–705. 1 indexed citations
13.
Inoue, Tomoaki & Ikuo Horii. (2002). Development of an Antigenicity Study Consisting of in vitro Priming in Mouse Peritoneal Exudate Cells and in vitro Anaphylaxis Test in Rat Mast Cells. 9(1). 17–28. 1 indexed citations
14.
Inoue, Tomoaki & Ikuo Horii. (2002). Effects on fetal thymocyte populations and postnatal T-cell-dependent immune functions after maternal exposure to 5-fluorouracil during pregnancy in mice.. The Journal of Toxicological Sciences. 27(2). 79–86. 4 indexed citations
15.
Kamei, Chiaki, Tomoaki Inoue, Yukihiko Sugimoto, & Hideki Masuda. (2000). Effects of peppermint extracts on experimental allergic rhinitis in rats.. 1(3). 61–66. 2 indexed citations
16.
Eliason, James F., Nadine S. Tare, Tomoaki Inoue, et al.. (2000). Extended Activity in Cynomolgus Monkeys of a Granulocyte Colony‐Stimulating Factor Mutein Conjugated With High Molecular Weight Polyethylene Glycol. Stem Cells. 18(1). 40–45. 10 indexed citations
17.
Inoue, Tomoaki & Ikuo Horii. (2000). Aromatic retinoid Ro 40-8757 reduces immunotoxicities of cyclophosphamide as revealed by immunohistochemical staining of lymphoid tissues and general pathologic examinations.. The Journal of Toxicological Sciences. 25(3). 189–198. 1 indexed citations
18.
Tare, Nadine S., Tomoaki Inoue, Motoo Yamasaki, et al.. (1999). Relationship between molecular mass and duration of activity of polyethylene glycol conjugated granulocyte colony-stimulating factor mutein. Experimental Hematology. 27(3). 425–432. 69 indexed citations
19.
Inoue, Tomoaki, et al.. (1997). [Renal artery embolism treated by selective intra-arterial infusion of tissue plasminogen activator: report of 2 cases].. PubMed. 43(9). 655–9. 2 indexed citations
20.
Inoue, Tomoaki, et al.. (1996). Comparative immunotoxicity assessment of N4-trimethoxybenzoyl-5'-deoxy-5-fluorocytidine (Ro 09-1390) and 5'-deoxy-5-fluorouridine (5'-DFUR) in BDF1 mice.. The Journal of Toxicological Sciences. 21(1). 29–39. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026